NVN1 Pill - orange oval, 14mm
Generic Name: valproic acid
Pill with imprint NVN1 is Orange, Oval and has been identified as Stavzor 250 mg. It is supplied by JDS Pharmaceuticals LLC.
Stavzor is used in the treatment of Bipolar Disorder; Epilepsy; Seizure Prevention; Seizures; Migraine Prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Stavzor 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVN1
Stavzor
- Generic Name
- valproic acid
- Imprint
- NVN1
- Strength
- 250 mg
- Color
- Orange
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- JDS Pharmaceuticals LLC
- National Drug Code (NDC)
- 68968-3250 (Discontinued)
- Inactive Ingredients
-
ammonia,
gelatin,
glycerin,
methacrylic acid - methyl methacrylate copolymer (1:1),
triethyl citrate,
water,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
More about Stavzor (valproic acid)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: fatty acid derivative anticonvulsants
- Breastfeeding
Patient resources
Other brands
Valproate Sodium, Depakene, Depacon
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
